Horizon buys Raptor for $800M
Horizon Pharma and Raptor Pharmaceutical Corp.have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued…
Pharmaceuticals, Biotechnology and Life Sciences
Horizon Pharma and Raptor Pharmaceutical Corp.have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued…
Verona Pharma #VRP appoints Vikas Sinha to the Board as a Non-Executive Director
The study, which will be conducted in up to 70 healthy individuals, aims to evaluate the tolerability of KarXT compared to xanomeline alone.
Dechra, an international specialist veterinary pharmaceuticals company, has received approval from the U.S. Food and Drug Administration (FDA) for a generic antibiotic.
Redx CFO steps down, the company searches new one
David Evans, Non-executive Chairman, has stepped down from the Board with immediate effect.
Quay Pharma will be formulating the capsules that will be administered in Redx’s trial.
PureTech gets grant for third U.S. patent for methods of treating infectious and allergic diseases
Positive Phase III EXPAND study for Novartis
“Second quarter financial performance was in-line with expectations.” – Olivier Brandicourt, Sanofi CEO